Six of the next 50 unicorns, or startups valued at $1 billion or more, are related to healthcare, according to a new analysis.
The New York Times and CB Insights — a research firm focused on predicting technology trends — partnered to compile a list of 50 "high-momentum" startups that the organizations believe will one day be unicorns. They identified the 50 companies using the Mosaic algorithm, a metric that combines a company's financial health, the amount of traction it has and the strength of its market.
NYT and CB Insights used the same approach in 2015 to develop a list of 50 future unicorns. Nearly half of those companies (48 percent) are unicorns today.
The two most common industries represented in NYT and CB Insights' 2019 list were (1) accounting and finance software and (2) business intelligence tools.
The six healthcare-related startups included in the analysis, listed in alphabetical order:
1. Alto Pharmacy (pharmacy)
2. Benchling (healthcare)
3. KRY (healthcare)
4. Medbanks Network Technology (healthcare)
5. Miaoshou Doctor (pharmacy)
6. Practo Technologies (healthcare)
To download NYT and CB Insights' report, click here.